CMG
51
-2
IVZ
62
-6
VFC
79
2
XYL
41
-6
HIG
50
-2
VNO
49
8
HON
59
-4
PSX
42
3
NRG
52
-8
GLW
67
2
ACN
50
-6
NEE
68
11
KO
44
-2
VMC
60
3
PG
53
-2
EIX
53
6
BA
40
-2
PCG
67
-2
MTCH
66
-9
MAR
59
-6
CMG
51
-2
IVZ
62
-6
VFC
79
2
XYL
41
-6
HIG
50
-2
VNO
49
8
HON
59
-4
PSX
42
3
NRG
52
-8
GLW
67
2
ACN
50
-6
NEE
68
11
KO
44
-2
VMC
60
3
PG
53
-2
EIX
53
6
BA
40
-2
PCG
67
-2
MTCH
66
-9
MAR
59
-6
Financhill
Back

Apogee Therapeutics, Inc. 10K Form

Buy
77

APGE
Apogee Therapeutics, Inc.

Last Price:
$76.85
Seasonality Move:
39.09%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive APGE News And Ratings

See the #1 stock for the next 7 days that we like better than APGE

APGE Financial Statistics

Sales & Book Value

Annual Sales: $0
Cash Flow: $-54.3M
Price / Cash Flow: 0
Annual Sales: $8.05
Price / Book: 8.94

Profitability

EPS (TTM): -4.31850
Net Income (TTM): $-253.7M
Gross Margin: $-189K
Return on Equity: -38.09%
Return on Assets: -35.95%

Apogee Therapeutics, Inc. Earnings Forecast

Key Apogee Therapeutics, Inc. Financial Ratios

  • Per Share Earnings over the last 3 years have been positive in 0 years.

Apogee Therapeutics, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: APGE
Website: apogeetherapeutics.com

Debt

Debt-to-Equity Ratio: 0.02
Current Ratio: 15.86
Quick Ratio: 15.49

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

APGE Technical Analysis vs Fundamental Analysis

Buy
77
Apogee Therapeutics, Inc. (APGE) is a Buy

Is Apogee Therapeutics, Inc. a Buy or a Sell?